Friday, February 2, 2018

Blood Cancer Journal - Table of Contents alert Volume 8 January 2018

If you are unable to see the message below, click here to view.
Blood Cancer Journal

Volume 8 (January 2018)

In this issue
Current Treatment Algorithm
Review Article
Sign up for e-alerts Sign up for e-alerts
Web feed


The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor

R Wu, A Sattarzadeh, B Rutgers, A Diepstra, A van den Berg et al.

Blood Cancer Journal 2018 8: 10.1038/bcj.2017.102

Abstract | Full Text

Current Treatment Algorithm

Essential thrombocythemia treatment algorithm 2018

Ayalew Tefferi, Alessandro M. Vannucchi & Tiziano Barbui

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0041-8

Abstract | Full Text

Polycythemia vera treatment algorithm 2018

Ayalew Tefferi, Alessandro M. Vannucchi & Tiziano Barbui

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0042-7

Abstract | Full Text


SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia

Patricia Johansson, Ludger Klein-Hitpass, Axel Choidas, Peter Habenberger, Bijan Mahboubi et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0036-5

Abstract | Full Text

Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response

Xueping Luo, Zefeng Xu, Bing Li, Tiejun Qin, Peihong Zhang et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0029-4

Abstract | Full Text

Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1

Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, Mikkael A. Sekeres, Betty K. Hamilton et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0040-9

Abstract | Full Text

Review Article

Pathogenesis of bone disease in multiple myeloma: from bench to bedside

Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou & Meletios A. Dimopoulos

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0037-4

Abstract | Full Text


Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers

Alissa Visram, Christopher Bredeson, David Allan, Mitchell Sabloff, Lothar Huebsch et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-018-0050-2

Abstract | Full Text

Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma

Kazuna Tanba, Yoshiaki Chinen, Hitoji Uchiyama, Nobuhiko Uoshima, Kazuho Shimura et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0043-6

Abstract | Full Text

Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition

Gabriela Galicia-Vázquez, Sarah Smith & Raquel Aloyz

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0039-2

Abstract | Full Text

EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental

Mrinal M. Patnaik, Rangit Vallapureddy, Terra L. Lasho, Katherine P. Hoversten, Christy M. Finke et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0045-4

Abstract | Full Text

Mutational heterogeneity of angioimmunoblastic T-cell lymphoma indicates distinct lymphomagenic pathways

Mathijs Willemsen, Myrurgia Abdul Hamid, Bjorn Winkens & Axel zur Hausen

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0047-2

Abstract | Full Text

Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia

Pablo Mozas, Alfredo Rivas-Delgado, Tycho Baumann, Neus Villamor, Valentín Ortiz-Maldonado et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0044-5

Abstract | Full Text

Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data

Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli & Tiziano Barbui

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0038-3

Abstract | Full Text

Normal karyotype in myelofibrosis: is prognostic integrity affected by the number of metaphases analyzed?

Maura Nicolosi, Mythri Mudireddy, Naseema Gangat, Animesh Pardanani, Curtis A. Hanson et al.

Blood Cancer Journal 2018 8: 10.1038/s41408-017-0046-3

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Blood Cancer Journal. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: